Today, Cooper University Health Care announced it has begun COVID-19 testing in its own laboratory. This announcement follows the announcement of last week that Cooper had launched a specimen collection location in Cherry Hill. Cooper now has the ability to both collect specimens and run tests all conducted by Cooper personnel.
“We are pleased to announce that Cooper will be able to test more of our patients as well as our team of tremendous doctors and nurses more quickly to slow the spread of COVID-19,” said George E. Norcross, III, Chairman of Cooper’s Board of Trustees.
Cooper is using test kits from Abbott Laboratories that are compatible with its laboratory equipment. Cooper’s trained team will begin running tests on its hospitalized patients immediately.
“As the leading academic health system and only trauma center in South Jersey, it is critical we can quickly determine positive COVID-19 patients to stop the spread of the virus, free up isolation rooms and space in the hospital for those who need to be there, and release those who are safe to be cared for elsewhere,” said Dr. Anthony Mazzarelli, Co-president/CEO of Cooper.
“Cooper plays an essential role in protecting the health and safety of the southern New Jersey region. Today’s testing announcement is a significant development for the communities we serve. Cooper will continue to do all we can to reduce the spread of this virus as well as continuing to care for those infected,” added Kevin O’Dowd, Co-president/CEO of Cooper.
About Cooper University Health Care
Cooper University Health Care is the leading academic health system in southern New Jersey with nearly 2 million annual patient visits to its hospital and more than 100 outpatient facilities. Cooper University Hospital is the only state-designated Level 1 Trauma Center in South Jersey and one of the busiest trauma centers in the region. For more information about Cooper University Health Care, visit CooperHealth.org.